Translational Lung Cancer Research

Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)

Hiren Mandaliya, Mark Jones, Christopher Oldmeadow et al. · 2019 · 388 citations · Full text

Medicine, Biostatistics, Oncology +16

Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes

Wei Zhang, Luc Girard, Yu‐An Zhang et al. · 2018 · 281 citations · Full text

Medicine, Cell Biology, Oncology +17

The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials

Yangyang Xu, Bing Wan, Xi Chen et al. · 2019 · 169 citations · Full text

Medicine, Immunology, Oncology +17

Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis

Yangbo Hu, Qun Zhang, Huijuan Li et al. · 2017 · 140 citations · Full text

Medicine, Oncology, Pharmacology +15

Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing

Clara Pérez-Barrios, Irene Nieto-Alcolado, María Torrente et al. · 2016 · 138 citations · Full text

Medicine, Molecular Biology, Oncology +16